Development of atherosclerotic calcification in apoE-deficient mice

被引：0
|
作者：
Shioi, A [1 ]
Kizu, A [1 ]
Jono, S [1 ]
Koyama, H [1 ]
Okuno, Y [1 ]
Nishizawa, Y [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Osaka 558, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(03)90650-7
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：151 / 152
页数：2
相关论文
共 50 条
  • [31] Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE-deficient mice
    Doddapattar, Prakash
    Radovic, Branislav
    Patankar, Jay V.
    Obrowsky, Sascha
    Jandl, Katharina
    Nusshold, Christoph
    Kolb, Dagmar
    Vujic, Nemanja
    Doshi, Lalit
    Chandak, Prakash G.
    Goeritzer, Madeleine
    Ahammer, Helmut
    Hoefler, Gerald
    Sattler, Wolfgang
    Kratky, Dagmar
    MOLECULAR NUTRITION & FOOD RESEARCH, 2013, 57 (10) : 1718 - 1728
  • [32] Effect of MMP-2 deficiency on atherosclerotic lesion formation in ApoE-deficient mice
    Kuzuya, M
    Nakamura, K
    Sasaki, T
    Cheng, XW
    Itohara, S
    Iguchi, A
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : 1120 - 1125
  • [33] FK506 immunosuppression inhibits collar-induced atherosclerotic plaque development in ApoE-deficient mice
    Donners, M
    Heeneman, S
    Bot, I
    de Windt, L
    van Berkel, T
    Daemen, M
    Biessen, E
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A49 - A50
  • [34] Compared effects of fluvastatin and irbesartan on vascular responses and atherosclerotic lesions in ApoE-deficient mice
    Gervais, M.
    Nicoletti, A.
    Cosson, C.
    Giudicelli, J. F.
    Richer, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 95 - 95
  • [35] Introducing a new model for studying macrophage homing into atherosclerotic plaque in apoE-deficient mice
    Litovsky, S
    Wyde, PR
    Madjid, M
    Akhtar, A
    Casscells, W
    Naghavi, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 255 - 255
  • [36] Oral administration of eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice
    Matsumoto, M.
    Sata, M.
    Soma, M.
    Tanaka, K.
    Fukuda, D.
    Nagai, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 448 - 448
  • [37] Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice
    Rune, Ida
    Rolin, Bidda
    Larsen, Christian
    Nielsen, Dennis Sandris
    Kanter, Jenny E.
    Bornfeldt, Karin E.
    Lykkesfeldt, Jens
    Buschard, Karsten
    Kirk, Rikke Kaae
    Christoffersen, Berit
    Fels, Johannes Josef
    Josefsen, Knud
    Kihl, Pernille
    Hansen, Axel Kornerup
    PLOS ONE, 2016, 11 (01):
  • [38] STREPTOCOCCUS PNEUMONIAE INFECTION PROMOTES THE LONG-TERM DEVELOPMENT OF AN ATHEROSCLEROTIC PHENOTYPE IN ATHEROPRONE APOE-DEFICIENT MICE
    Peters, Lisa
    Simmons, Szandor
    Ginsbach, Laura
    Rad, Pegah Ramezani
    Nageswaran, Vanasa
    Brack, Markus
    Behrendt, Ulrike
    Nouailles, Geraldine
    Haghikia, Arash
    Witzenrath, Martin
    Kuebler, Wolfgang
    ATHEROSCLEROSIS, 2024, 395
  • [39] Simvastatin promotes atherosclerotic plaque stability in ApoE-deficient mice independently of lipid lowering
    Bea, F
    Blessing, E
    Bennett, B
    Levitz, M
    Wallace, EP
    Rosenfeld, ME
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (11) : 1832 - 1837
  • [40] Anti-Atherosclerotic Effects of Dihomo-γ-Linolenic Acid in ApoE-Deficient Mice
    Takai, Shinji
    Jin, Denan
    Kawashima, Hiroshi
    Kimura, Maki
    Shiraishi-Tateishi, Akiko
    Tanaka, Takao
    Kakutani, Saki
    Tanaka, Kazuhiko
    Kiso, Yoshinobu
    Miyazaki, Mizuo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (04) : 480 - 489
12345